Elisabeth Bjork - Aug 27, 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Elisabeth Bjork
Stock symbol
RCKT
Transactions as of
Aug 27, 2025
Transactions value $
$34,100
Form type
4
Date filed
8/27/2025, 08:54 PM
Previous filing
Jul 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bjork Elisabeth Director C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ Martin Wilson, as attorney-in-fact for Elisabeth Bjork 2025-08-27 0001810406

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Purchase $34.1K +10K +33.33% $3.41 40K Aug 27, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 30,000 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis and vest in full on June 18, 2026.